Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

  • 3 of 6

Alex Zhavoronkov, chief executive officer of artificial intelligence start-up Insilico Medicine, says that in the past couple of years the pharmaceutical industry investment tap into artificial intelligence has started to flow

Alex Zhavoronkov, chief executive officer of artificial intelligence start-up Insilico Medicine, believes that in the very near future, human [intelligence] in many cases will become irrelevant

Source  Courtesy of Alex Zhavoronkov